A citation-based method for searching scientific literature

Sheryl L Chow, Robert L Page, Christophe Depre. Expert Rev Cardiovasc Ther 2018
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


5
50


Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials.
John G F Cleland, Karina V Bunting, Marcus D Flather, Douglas G Altman, Jane Holmes, Andrew J S Coats, Luis Manzano, John J V McMurray, Frank Ruschitzka, Dirk J van Veldhuisen,[...]. Eur Heart J 2018
217
50

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Piotr Ponikowski, Adriaan A Voors, Stefan D Anker, Héctor Bueno, John G F Cleland, Andrew J S Coats, Volkmar Falk, José Ramón González-Juanatey, Veli-Pekka Harjola, Ewa A Jankowska,[...]. Eur J Heart Fail 2016
50

Mid-range left ventricular ejection fraction: Clinical profile and cause of death in ambulatory patients with chronic heart failure.
Domingo A Pascual-Figal, Andreu Ferrero-Gregori, Ines Gomez-Otero, Rafael Vazquez, Juan Delgado-Jimenez, Jesus Alvarez-Garcia, Juan R Gimeno-Blanes, Fernando Worner-Diz, Alfredo Bardají, Luis Alonso-Pulpon,[...]. Int J Cardiol 2017
43
50

Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry.
Ovidiu Chioncel, Mitja Lainscak, Petar M Seferovic, Stefan D Anker, Maria G Crespo-Leiro, Veli-Pekka Harjola, John Parissis, Cecile Laroche, Massimo Francesco Piepoli, Candida Fonseca,[...]. Eur J Heart Fail 2017
270
50

HCN channels expressed in the inner ear are necessary for normal balance function.
Geoffrey C Horwitz, Jessica R Risner-Janiczek, Sherri M Jones, Jeffrey R Holt. J Neurosci 2011
36
50

Characterization of HCN and cardiac function in a colonial ascidian.
Annette Hellbach, Stefano Tiozzo, Jungho Ohn, Michael Liebling, Anthony W De Tomaso. J Exp Zool A Ecol Genet Physiol 2011
8
50

Recent advances in heart failure.
Mahwash Kassi, Bashar Hannawi, Barry Trachtenberg. Curr Opin Cardiol 2018
10
50

Inhibition of hyperpolarization-activated cyclic nucleotide-gated channels by β-blocker carvedilol.
Ying Cao, Shujun Chen, Yemei Liang, Ting Wu, Jianxin Pang, Shuwen Liu, Pingzheng Zhou. Br J Pharmacol 2018
8
50

Pharmacological Interventions Effective in Improving Exercise Capacity in Heart Failure.
Cristiana Vitale, Spoletini Ilaria, Giuseppe Mc Rosano. Card Fail Rev 2018
6
50

Mechanisms of phosphenes in irradiated patients.
Thibaud Mathis, Stephane Vignot, Cecila Leal, Jean-Pierre Caujolle, Celia Maschi, Martine Mauget-Faÿsse, Laurent Kodjikian, Stéphanie Baillif, Joel Herault, Juliette Thariat. Oncotarget 2017
6
50

Ivabradine and atrial fibrillation: A double-edged sword.
Yanmeng Lu, Ketian Li, Xiushi Suzy Liu, Nixiao Zhang, Guangping Li, Tong Liu. Int J Cardiol 2016
3
50

Pleiotropic, heart rate-independent cardioprotection by ivabradine.
P Kleinbongard, N Gedik, P Witting, B Freedman, N Klöcker, G Heusch. Br J Pharmacol 2015
49
50

Novel pharmacological activity of loperamide and CP-339,818 on human HCN channels characterized with an automated electrophysiology assay.
Yan T Lee, Dmitry V Vasilyev, Qin J Shan, John Dunlop, Scott Mayer, Mark R Bowlby. Eur J Pharmacol 2008
23
50

Heart rate reduction via selective 'funny' channel blockers.
Annalisa Bucchi, Andrea Barbuti, Mirko Baruscotti, Dario DiFrancesco. Curr Opin Pharmacol 2007
53
50

Hyperpolarization-Activated Cyclic Nucleotide-Gated Non-selective (HCN) Ion Channels Regulate Human and Murine Urinary Bladder Contractility.
Felix Mader, Steffen Müller, Ludwig Krause, Armin Springer, Karoline Kernig, Chris Protzel, Katrin Porath, Simone Rackow, Tristan Wittstock, Marcus Frank,[...]. Front Physiol 2018
6
50

Development of correction formula for field potential duration of human induced pluripotent stem cell-derived cardiomyocytes sheets.
Hiroko Izumi-Nakaseko, Yasunari Kanda, Yuji Nakamura, Mihoko Hagiwara-Nagasawa, Takeshi Wada, Kentaro Ando, Atsuhiko T Naito, Yuko Sekino, Atsushi Sugiyama. J Pharmacol Sci 2017
11
50


Safety of ivabradine in patients with coronary artery disease and left ventricular systolic dysfunction (from the BEAUTIFUL Holter Substudy).
Michal Tendera, Mario Talajic, Michele Robertson, Jean-Claude Tardif, Roberto Ferrari, Ian Ford, P Gabriel Steg, Kim Fox. Am J Cardiol 2011
25
50

Cardiac pacemaker channel (HCN4) inhibition and atrial arrhythmogenesis after releasing cardiac sympathetic activation.
Kristine Chobanyan-Jürgens, Karsten Heusser, David Duncker, Christian Veltmann, Marcus May, Heidrun Mehling, Friedrich C Luft, Christoph Schröder, Jens Jordan, Jens Tank. Sci Rep 2018
3
50


Chronic Treatment with Ivabradine Does Not Affect Cardiovascular Autonomic Control in Rats.
Fernanda C Silva, Franciny A Paiva, Flávia C Müller-Ribeiro, Henrique M A Caldeira, Marco A P Fontes, Rodrigo C A de Menezes, Karina R Casali, Gláucia H Fortes, Eleonora Tobaldini, Monica Solbiati,[...]. Front Physiol 2016
8
50

Ivabradine: Current and Future Treatment of Heart Failure.
Lene Thorup, Ulf Simonsen, Daniela Grimm, Elise R Hedegaard. Basic Clin Pharmacol Toxicol 2017
12
50


Heart Rate and Rhythm and the Benefit of Beta-Blockers in Patients With Heart Failure.
Dipak Kotecha, Marcus D Flather, Douglas G Altman, Jane Holmes, Giuseppe Rosano, John Wikstrand, Milton Packer, Andrew J S Coats, Luis Manzano, Michael Böhm,[...]. J Am Coll Cardiol 2017
124
50

Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial.
Michel Komajda, Richard Isnard, Alain Cohen-Solal, Marco Metra, Burkert Pieske, Piotr Ponikowski, Adriaan A Voors, Fabienne Dominjon, Cécile Henon-Goburdhun, Matthieu Pannaux,[...]. Eur J Heart Fail 2017
99
50

An evaluation of the pharmacokinetics and pharmacodynamics of ivabradine for the treatment of heart failure.
Gian Marco Rosa, Simone Ferrero, Paola Ghione, Alberto Valbusa, Claudio Brunelli. Expert Opin Drug Metab Toxicol 2014
9
50

Regulation of cytochrome P450 gene expression by ketamine: a review.
Jui-Tai Chen, Li Wei, Ta-Liang Chen, Chun-Jen Huang, Ruei-Ming Chen. Expert Opin Drug Metab Toxicol 2018
4
50

Benefits of Heart Rate Slowing With Ivabradine in Patients With Systolic Heart Failure and Coronary Artery Disease.
Jeffrey S Borer, Prakash C Deedwania, Jae B Kim, Michael Böhm. Am J Cardiol 2016
15
50

Decreased hyperpolarization-activated cyclic nucleotide-gated channels are involved in bladder dysfunction associated with spinal cord injury.
Qian Liu, Chao Wu, Shengquan Huang, Qingjian Wu, Tao Zhou, Xiaobing Liu, Xin Liu, Xiaoyan Hu, Longkun Li. Int J Mol Med 2018
4
50

Physiology and pharmacology of the cardiac pacemaker ("funny") current.
Mirko Baruscotti, Annalisa Bucchi, Dario Difrancesco. Pharmacol Ther 2005
214
50

Simultaneous determination of ivabradine and its metabolites in human plasma by liquid chromatography--tandem mass spectrometry.
M François-Bouchard, G Simonin, Bossant, C Boursier-Neyret. J Chromatogr B Biomed Sci Appl 2000
20
50

Influence of Ivabradine on the Anticonvulsant Action of Four Classical Antiepileptic Drugs Against Maximal Electroshock-Induced Seizures in Mice.
Katarzyna M Sawicka, Agnieszka Wawryniuk, Agnieszka Zwolak, Jadwiga Daniluk, Monika Szpringer, Magdalena Florek-Luszczki, Bartlomiej Drop, Dorota Zolkowska, Jarogniew J Luszczki. Neurochem Res 2017
10
50

Ivabradine Aggravates the Proarrhythmic Risk in Experimental Models of Long QT Syndrome.
Gerrit Frommeyer, Jan Weller, Christian Ellermann, Patrick Leitz, Simon Kochhäuser, Philipp S Lange, Dirk G Dechering, Lars Eckardt. Cardiovasc Toxicol 2019
6
50

Effective suppression of atrial fibrillation by ivabradine: Novel target for an established drug?
Gerrit Frommeyer, Magdalena Sterneberg, Dirk G Dechering, Christian Ellermann, Nils Bögeholz, Simon Kochhäuser, Christian Pott, Michael Fehr, Lars Eckardt. Int J Cardiol 2017
12
50

Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy.
Jean-Claude Tardif, Eileen O'Meara, Michel Komajda, Michael Böhm, Jeffrey S Borer, Ian Ford, Luigi Tavazzi, Karl Swedberg. Eur Heart J 2011
201
50

How does ivabradine effect erectile dysfunction in patients with heart failure?
Fatih Aydın, Serkan Bektur, Yasin Taşdelen, Yüksel Kıvrak, Ayşe Hüseyinoglu Aydın. Kardiol Pol 2017
3
50

Synthesis of Polyheterocyclic Pyrrolo[3,4-b]pyridin-5-ones via a One-Pot (Ugi-3CR/aza Diels-Alder/N-acylation/aromatization/SN2) Process. A Suitable Alternative towards Novel Aza-Analogues of Falipamil.
Angel Zamudio-Medina, Ailyn N García-González, Genesis K Herrera-Carrillo, Daniel Zárate-Zárate, Adriana Benavides-Macías, Joaquín Tamariz, Ilich A Ibarra, Alejandro Islas-Jácome, Eduardo González-Zamora. Molecules 2018
3
50

Siponimod pharmacokinetics, safety, and tolerability in combination with rifampin, a CYP2C9/3A4 inducer, in healthy subjects.
Anne Gardin, Cathy Gray, Srikanth Neelakantham, Felix Huth, Antonia M Davidson, Swati Dumitras, Eric Legangneux, Kasra Shakeri-Nejad. Eur J Clin Pharmacol 2018
9
50

Quality of life improvement in older patients with heart failure initiated on ivabradine: Results from the UK multi-centre LIVE:LIFE prospective cohort study.
D Zachariah, D Stevens, G Sidorowicz, C Spooner, N Rowell, J Taylor, R Kay, M S Salek, P R Kalra. Int J Cardiol 2017
12
50

Role of ivabradine in management of stable angina in patients with different clinical profiles.
Juan Carlos Kaski, Steffen Gloekler, Roberto Ferrari, Kim Fox, Bernard I Lévy, Michel Komajda, Panos Vardas, Paolo G Camici. Open Heart 2018
5
50

Analysis of variants in the HCN4 gene and in three single nucleotide polymorphisms of the CYP3A4 gene for association with ivabradine reduction in heart rate: A preliminary report.
Lucía Núñez, María G Crespo-Leiro, Grecia M Marrón-Liñares, Natalia Suarez-Fuentetaja, Eduardo Barge-Caballero, María Jesús Paniagua-Martín, Raquel Marzoa-Rivas, Zulaika Grille-Cancela, Javier Muñiz-García, Jose Manuel Vazquez-Rodriguez,[...]. Cardiol J 2016
3
50

Human cytochrome P450 expression in bacteria: Whole-cell high-throughput activity assay for CYP1A2, 2A6 and 3A4.
Francisco Esteves, Diana Campelo, Philippe Urban, Sophie Bozonnet, Thomas Lautier, José Rueff, Gilles Truan, Michel Kranendonk. Biochem Pharmacol 2018
3
50

What Can Be Learned from Recent New Drug Applications? A Systematic Review of Drug Interaction Data for Drugs Approved by the US FDA in 2015.
Jingjing Yu, Zhu Zhou, Katie H Owens, Tasha K Ritchie, Isabelle Ragueneau-Majlessi. Drug Metab Dispos 2017
30
50

Symptomatic Bradycardia and Heart Failure Triggered by Ivabradine in a Patient Receiving Antiretroviral Therapy.
José M Romero-León, María C Gálvez-Contreras, Luis F Díez-García. Rev Esp Cardiol (Engl Ed) 2016
5
50


The effect of hyperpolarization-activated cyclic nucleotide-gated ion channel inhibitors on the vagal control of guinea pig airway smooth muscle tone.
Alice E McGovern, Jed Robusto, Joanna Rakoczy, David G Simmons, Simon Phipps, Stuart B Mazzone. Br J Pharmacol 2014
5
50


Ivabradine Treatment Reduces Cardiomyocyte Apoptosis in a Murine Model of Chronic Viral Myocarditis.
Ge Li-Sha, Liu Li, Zhou De-Pu, Shi Zhe-Wei, Gu Xiaohong, Chen Guang-Yi, Li Jia, Lin Jia-Feng, Chu Maoping, Li Yue-Chun. Front Pharmacol 2018
4
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.